Buscar
Congreso SOLACI

Búsqueda de: transcatheter mitral valve

Si no está conforme con los resultados, inténtelo de nuevamente.
Structural heart disease

2 Year Outcomes of Transcatheter Mitral Valve Replacement with Intrepid

Severe mitral valve insufficiency (MI) has been associated to the progressive deterioration of left ventricular function, cardiac...
solaci -
Ir
Mitral valve

Promising Results of Transcatheter Mitral Valve Replacement in Bioprosthesis Failure

Failure of a mitral bioprosthesis always poses a challenge regarding decision-making, especially when dealing with elderly patients...
solaci -
Ir
Structural Heart Disease

EuroPCR 2020 | EVOQUE: New Transcatheter Mitral Valve Replacement System, Promises at Short Term and Future Hope

Transeptal transcatheter mitral valve replacement offers a less invasive alternative vs. surgery and with fewer anatomical limitations...
solaci -
Ir
Mitral valve

Promising Outcomes of Transcatheter Mitral Valve Replacement in Complex Patients

Courtesy of Dr. Carlos Fava. The risk of repeat surgical mitral valve repair involves 6% to15% mortality at...
solaci -
Ir
Mitral valve

Virtual ACC 2020 | Unlike in TAVR, the Number of Mitral Valve Surgeries Does Not Improve the Outcomes of Transcatheter Mitral Valve Repairs

Soon, our website will feature an interesting study showing that sites with a higher number of conventional...
solaci -
Ir
Mitral valve

TCT 2017 | MAVERIC: Results 6 Months After Transcatheter Mitral Valve Replacement

 Courtesy of the SBHCI. This seems to be the year for transcatheter mitral valve devices, and the ARTO...
solaci -
Ir
Congenital cardiopathy

SOLACI CACI 2017 | Perspectives of Transcatheter mitral valve replacement (TMVR): early data

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. José...
solaci -
Ir
DAY 2

Mitral Valve Global Registry: transcatheter mitral valve replacement due to native valve disease

Courtesy of the SBHCI. The risk of surgical mitral valve replacement in patients with significant annular calcification is...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad